Funding for this research was provided by:
King's College London
First Online: 8 May 2018
Compliance with Ethical Standards
: Wee Liak Hoo is a co-investigator for LIBERTY 1—An International Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study to Evaluate Relugolix Co-Administered with and without Low-Dose Estradiol and Norethindrone Acetate in Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids. Srirupa Ghosh, Joel Naftalin and Rachel Imrie declare no conflict of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.